Sr. Correspondent, Broker Research, Bangalore, India
Saqib's Feed
Oct 9, 2014

Stock option volumes soar for biotechs with Ebola drugs

NEW YORK (Reuters) – The newest twist in the business of trying to capitalize on the outbreak of the Ebola virus is playing out in the U.S. equity options market.

Trading volumes have soared in the stock options of a pair of biotechnology companies thought to have promising treatments for the deadly disease which has claimed the lives of 3,865 people worldwide, according to the World Health Organization.

Oct 9, 2014
Oct 8, 2014
Oct 8, 2014

Herbalife options attract bearish bets

NEW YORK (Reuters) – Herbalife Ltd (HLF.N: Quote, Profile, Research, Stock Buzz) options attracted some bearish bets on Wednesday, a day after a news report that said the U.S. Federal Trade Commission may take disciplinary action against the nutritional products maker, whose distribution model has been the subject of controversy.

Fox Business Network reported on Tuesday that Herbalife executives told investors that the FTC may move against it, but was unlikely to shut it down.

Oct 8, 2014
Oct 8, 2014
Oct 8, 2014
Oct 7, 2014
Oct 7, 2014
Oct 7, 2014
    • About Saqib

      "Saqib is Senior correspondent, Broker Research and leads a team of five reporters covering equities research. He previously worked as a producer on the Reuters Global Online desk. He joined Reuters in 2009 after graduating from the Asian College of Journalism."
      Joined Reuters:
      2009
      Languages:
      English, Hindi, Bengali
    • More from Saqib

    • Contact Saqib

    • Follow Saqib